Success Metrics

Clinical Success Rate
90.9%

Based on 60 completed trials

Completion Rate
91%(60/66)
Active Trials
4(5%)
Results Posted
17%(10 trials)
Terminated
6(7%)

Phase Distribution

Ph not_applicable
3
4%
Ph phase_2
9
11%
Ph phase_1
6
7%

Phase Distribution

6

Early Stage

9

Mid Stage

0

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
6(33.3%)
Phase 2Efficacy & side effects
9(50.0%)
N/ANon-phased studies
3(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

89.6%

60 of 67 finished

Non-Completion Rate

10.4%

7 ended early

Currently Active

4

trials recruiting

Total Trials

84

all time

Status Distribution
Active(4)
Completed(60)
Terminated(7)
Other(13)

Detailed Status

Completed60
unknown13
Terminated6
Active, not recruiting3
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
84
Active
4
Success Rate
90.9%
Most Advanced
Phase 2

Trials by Phase

Phase 16 (33.3%)
Phase 29 (50.0%)
N/A3 (16.7%)

Trials by Status

recruiting11%
terminated67%
unknown1315%
completed6071%
withdrawn11%
active_not_recruiting34%

Recent Activity

Clinical Trials (84)

Showing 20 of 84 trialsScroll for more
NCT04671940

Exploratory Study of Clonal Evolution in Cancer for Patients Undergoing Transoral Robotic Surgery for Radiation Exposed Residual/reCurrent Tumours of the Upper Aerodigestive Tract

Recruiting
NCT01199562

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Active Not Recruiting
NCT00335816Phase 2

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Active Not Recruiting
NCT00977457Phase 1

Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery

Active Not Recruiting
NCT04273672

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

Completed
NCT00445965Phase 2

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Completed
NCT00667563Phase 1

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Completed
NCT01206465Phase 1

Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors

Completed
NCT01004640

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

Unknown
NCT00900224

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Unknown
NCT01267812Phase 2

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

Completed
NCT01407770

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Completed
NCT01567722

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Terminated
NCT05090605

The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population

Completed
NCT05090631

The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh Population

Completed
NCT05088499

The Role of Genetic Factors in the Development of Epilepsy in the Kazakh Population

Completed
NCT05088486

The Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh Population

Completed
NCT05090618

The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population

Completed
NCT05090644

Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic Group

Completed
NCT01261247Phase 2

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Completed

Drug Details

Intervention Type
GENETIC
Total Trials
84